Ocimum basilicum attenuates ethidium bromide-induced cognitive deficits and pre-frontal cortical neuroinflammation,

Debapriya Garabadu1, Deepanshu Singh2

  • 1Division of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, 281406, India. debapriya.garabadu@gla.ac.in.

Metabolic Brain Disease
|January 31, 2020
PubMed

Insights

Ocimum basilicum essential oil shows therapeutic potential for multiple sclerosis (MS) by reducing cognitive deficits, neuroinflammation, and mitochondrial dysfunction in rats. This herbal medicine may offer an alternative treatment for MS patients.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Herbal Medicine Research

Background:

  • Multiple sclerosis (MS) is a chronic neurodegenerative disease characterized by neuroinflammation and demyelination.
  • Current disease-modifying drugs for MS have limited effectiveness, prompting research into alternative therapies.
  • Herbal medicines are increasingly recognized for their potential therapeutic benefits in managing chronic conditions like MS.

Purpose of the Study:

  • To evaluate the therapeutic potential of Ocimum basilicum essential oil (OB) in an ethidium bromide (EB)-induced rat model of MS.
  • To investigate the effects of OB on cognitive deficits, neuroinflammation, astrogliosis, and mitochondrial dysfunction in the pre-frontal cortex (PFC) of rats.

Main Methods:

  • An animal model of MS was induced in male rats using bilateral intracerebroventricular injection of ethidium bromide (EB).
  • Rats were treated with varying doses of Ocimum basilicum essential oil (OB) (50, 100, and 200 μL/kg) or Ursolic acid (UA).
  • Cognitive function was assessed using the Morris water maze and Y-maze tests. Neuroinflammation, astrogliosis, mitochondrial function, and apoptosis in the PFC were evaluated.

Main Results:

  • OB (100 and 200 μL/kg) and UA significantly ameliorated EB-induced cognitive deficits.
  • OB (100 and 200 μL/kg) and UA markedly reduced neuroinflammation by decreasing pro-inflammatory cytokines (TNF-alpha, IL-6) and astrogliosis markers (GFAP, Iba-1) in the PFC.
  • OB (100 and 200 μL/kg) and UA significantly improved mitochondrial function and reduced apoptosis in the PFC.

Conclusions:

  • Ocimum basilicum essential oil demonstrates significant therapeutic potential in mitigating MS-like symptoms in a rat model.
  • OB effectively reduces cognitive impairment, neuroinflammation, astrogliosis, and mitochondrial dysfunction associated with MS.
  • OB may serve as a promising alternative therapeutic agent for the pharmacotherapy of multiple sclerosis.

Related Concept Videos